KYTX Financials
Kyverna Therapeutics Inc - Financial statements & key metrics
Stock Price
$8.94
Market Cap
$579.16M
EPS
$-3.77
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-127.48M
EPS (Diluted)
$-3.33
Balance Sheet Highlights
Total Assets
$304.64M
Total Liabilities
$38.06M
Shareholders Equity
-
Cash & Equivalents
$96.62M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-114.25M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-0.6%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KYTX revenue?
View KYTX's income statement for detailed revenue data.
Is KYTX profitable?
KYTX reported a loss of $127.48M in the most recent quarter.
What is KYTX market cap?
KYTX has a market capitalization of $579.16M, making it a small-cap stock.
Does KYTX have debt?
View KYTX's balance sheet for debt information.
What is KYTX cash flow?
Cash flow data is available in the full financial statements.